The Hope and Hype of CRISPR-Cas9 Genome Editing A Review

被引:38
作者
Musunuru, Kiran [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA
关键词
PLURIPOTENT STEM-CELLS; IN-VIVO; MUSCULAR-DYSTROPHY; MOUSE MODEL; CAS9; EFFICIENCY; NUCLEASES; SPECIFICITY; GENERATION; DISEASE;
D O I
10.1001/jamacardio.2017.1713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (CRISPR-Cas9) has garnered a great degree of attention since its first reported uses in mammalian cells in early 2013 due to its perceived impact with respect to potential research applications and, especially, therapeutic applications. OBSERVATIONS CRISPR-Cas9 is being widely used in the laboratory and has greatly improved the ability to generate genetically modified animal models of human diseases. First steps have been reported with respect to proof-of-concept cardiovascular therapeutic applications in mouse models which might eventually lead to new treatments for patients as well as modification of human embryos, which raises a host of social, ethical, and legal questions. CONCLUSIONS AND RELEVANCE CRISPR-Cas9 is already having a substantial effect on cardiovascular basic science research. Although the first steps toward potential therapies have been taken, there are substantial obstacles that will need to be overcome if CRISPR-Cas9 is to be used in the practice of cardiovascular medicine.
引用
收藏
页码:914 / 919
页数:6
相关论文
共 43 条
[1]   The Public and the Gene-Editing Revolution [J].
Blendon, Robert J. ;
Gorski, Mary T. ;
Benson, John M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (15) :1406-1411
[2]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[3]   Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272
[4]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[5]   Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing [J].
Ding, Qiurong ;
Strong, Alanna ;
Patel, Kevin M. ;
Ng, Sze-Ling ;
Gosis, Bridget S. ;
Regan, Stephanie N. ;
Cowan, Chad A. ;
Rader, Daniel J. ;
Musunuru, Kiran .
CIRCULATION RESEARCH, 2014, 115 (05) :488-+
[6]   Enhanced Efficiency of Human Pluripotent Stem Cell Genome Editing through Replacing TALENs with CRISPRs [J].
Ding, Qiurong ;
Regan, Stephanie N. ;
Xia, Yulei ;
Oostrom, Leonie A. ;
Cowan, Chad A. ;
Musunuru, Kiran .
CELL STEM CELL, 2013, 12 (04) :393-394
[7]   Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases [J].
Frock, Richard L. ;
Hu, Jiazhi ;
Meyers, Robin M. ;
Ho, Yu-Jui ;
Kii, Erina ;
Alt, Frederick W. .
NATURE BIOTECHNOLOGY, 2015, 33 (02) :179-186
[8]   Improving CRISPR-Cas nuclease specificity using truncated guide RNAs [J].
Fu, Yanfang ;
Sander, Jeffry D. ;
Reyon, Deepak ;
Cascio, Vincent M. ;
Joung, J. Keith .
NATURE BIOTECHNOLOGY, 2014, 32 (03) :279-284
[9]  
Gartner Inc, RES METH GARTN HYP C
[10]   Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9 [J].
Gupta, Rajat M. ;
Musunuru, Kiran .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) :4154-4161